Tag Archives | abiraterone acetate price

Abiraterone price may be discounted 40% for UK NICE approval

At the recent European Association of Urology (EAU) Annual Congress in Paris, one of the rumours was that the price of abiraterone (Zytiga) has been discounted 40% to the UK National Health Service (NHS) in order to obtain reimbursement approval from the National Institute for Health & Clinical Excellence (NICE). As Sally notes in her […]

Continue Reading

Zytiga (abiraterone acetate) price will impact the Prostate Cancer market following FDA approval

Sally Church on Pharma Strategy Blog has written about the FDA approval yesterday of Ortho Biotech’s ($JNJ) abiraterone acetate, brand name Zytiga for the treatment of castration resistant prostate cancer in patients who have received prior chemotherapy with docetaxel. The final data showed a 4.6 month increase in overall survival (OS) in these very sick […]

Continue Reading

error: Content is protected !!